Medical News

RSS

SPIE to honor CCNY professor with Britton Chance Biomedical Optics Award

A scientific innovator from The City College of New York (CCNY) whose research unites the divergent fields of medicine, biology and high-speed laser physics will be honored this month for his pioneering work in biomedical optics by SPIE, the international society for optics and photonics.

7 Jan 2012

Thermo Fisher Scientific's Unity Lab Services to optimize productivity and reduce costs

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Unity Lab Services, a new offering that combines product and laboratory support services to create a single solution for customers to optimize productivity and reduce their total cost of laboratory operations.

From Thermo Fisher Scientific Inc. 7 Jan 2012

Humana to lead community well-being initiatives in La Quinta, Calif

Humana Inc., one of the nation's leading health care companies, will lead numerous community well-being initiatives in La Quinta, Calif. surrounding the inaugural Humana Challenge golf tournament.

7 Jan 2012

Physicians Practice announces results of 2011 Fee Schedule Survey

UBM Medica's Physicians Practice today announced the results of the 2011 Fee Schedule Survey. Topline results of the survey show a continuing decline in payment to doctors from insurance companies and Medicare that has been underway for at least a decade.

7 Jan 2012

Analysis and examination: Detailing the records, evolution of GOP presidential primary candidates

Media outlets report on what Rick Santorum did after he left the Senate and what he would have on his to-do list if elected, the continuing "risks" Mitt Romney faces from the left and the right, and on an ethics group that is directing a challenge at Newt Gingrich.

7 Jan 2012

PCI Biotech focuses on localised cancer therapy with minimum side effects

Side effects are currently the biggest problem with any cancer treatment. A Norwegian biotech company is drawing closer to the goal of creating a treatment which kills only cancer cells, leaving other cells unaffected.

7 Jan 2012

VirtualScopics receives NASDAQ Stock Market notice

VirtualScopics, Inc., a leading provider of image-based solutions to the pharmaceutical, biotechnology and medical device industries, announced today that on January 4, 2012 it received a notice from the NASDAQ Stock Market indicating that the Company's minimum bid price has fallen below $1.00 for 30 consecutive business days.

7 Jan 2012

VisionGate achieves full automation of Cell-CT system

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has achieved full automation of its Cell-CT system, a proprietary imaging platform that generates high-resolution 3D biosignatures from intact cells.

7 Jan 2012

Studies identify genes and small molecules against protein conformational diseases

Two related studies from Northwestern University offer new strategies for tackling the challenges of preventing and treating diseases of protein folding, such as Alzheimer's, Parkinson's and Huntington's diseases, amyotrophic lateral sclerosis (ALS), cancer, cystic fibrosis and type 2 diabetes.

7 Jan 2012

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Today's research comes from the Annals of Internal Medicine, the Journal of the American Medical Association, the Archives of Pediatrics and Adolescent Medicine, George Washington University and the Robert Wood Johnson Foundation.

7 Jan 2012

USPTO issues patent to Tris Pharma's OralXR+ platform

Tris Pharma, an emerging specialty pharmaceutical company, announced the US grant of its core technology patent for its OralXR+ platform. This is the first patent grant of a substantial estate filed by Tris Pharma and covers a multitude of actives having modified release formulations comprising drug-ion exchange resin complexes.

7 Jan 2012

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

Pearl Therapeutics Inc. today announced the completion of two Phase 2b clinical studies of PT003, the Company's investigational inhaled combination bronchodilator product for the treatment of patients with moderate-to-severe COPD.

7 Jan 2012

Study on benefits of Brain Wave Vibration meditation method

BEST Life Media, publisher of the Award Winning Brain Wave Vibration, and other books on health and wellness and the mind-body connection, is pleased to announce the results of a recent study concerning the Brain Wave Vibration meditation method.

7 Jan 2012

Mazor Robotics receives European patent titled, 'Miniature Bone-mounted Surgical Robot'

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that the European Patent Office granted European Patent No. 1414362 entitled "Miniature Bone-mounted Surgical Robot," which covers the Company's flagship product, Renaissance.

7 Jan 2012

First Bright Now! Dental office opens in Orlando

Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its first Bright Now! Dental office of the new year, in Orlando, FL. This new office in Orlando Square will be the fifth Bright Now! Dental office in the Orlando area. The first Bright Now! Dental office in the Orlando market opened in May, 2011 in Casselberry, FL.

7 Jan 2012

FDA approval of raltegravir offers new weapon to treat HIV infection in children

For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.

7 Jan 2012

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled "Device for the Application of Acoustic Shock Waves."

7 Jan 2012

Supernus secures $42M through two transactions

Supernus Pharmaceuticals, Inc. today announced that in December 2011 it closed two transactions through which it raised $42 million.

7 Jan 2012

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

7 Jan 2012

Synta prices underwritten public offering of 7,000,000 shares of common stock

Synta Pharmaceuticals Corp. announced today that it has priced an underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $4.40 per share.

7 Jan 2012

Medical News

SPIE to honor CCNY professor with Britton Chance Biomedical Optics Award

Thermo Fisher Scientific's Unity Lab Services to optimize productivity and reduce costs

Humana to lead community well-being initiatives in La Quinta, Calif

Physicians Practice announces results of 2011 Fee Schedule Survey

Analysis and examination: Detailing the records, evolution of GOP presidential primary candidates

PCI Biotech focuses on localised cancer therapy with minimum side effects

VirtualScopics receives NASDAQ Stock Market notice

VisionGate achieves full automation of Cell-CT system

Studies identify genes and small molecules against protein conformational diseases

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

USPTO issues patent to Tris Pharma's OralXR+ platform

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

Study on benefits of Brain Wave Vibration meditation method

Mazor Robotics receives European patent titled, 'Miniature Bone-mounted Surgical Robot'

First Bright Now! Dental office opens in Orlando

FDA approval of raltegravir offers new weapon to treat HIV infection in children

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

Supernus secures $42M through two transactions

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Synta prices underwritten public offering of 7,000,000 shares of common stock

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News